Akebia Therapeutics, Inc. (AKBA)
0.67
-0.03
(-3.67%)
USD |
NASDAQ |
Oct 16, 16:00
0.6731
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Net Income (TTM) : -29.67M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.67M |
| March 31, 2026 | -20.51M |
| December 31, 2025 | -5.345M |
| September 30, 2025 | -15.90M |
| June 30, 2025 | -36.48M |
| March 31, 2025 | -45.31M |
| December 31, 2024 | -69.41M |
| September 30, 2024 | -45.99M |
| June 30, 2024 | -40.44M |
| March 31, 2024 | -43.03M |
| December 31, 2023 | -51.92M |
| September 30, 2023 | -61.75M |
| June 30, 2023 | -101.36M |
| March 31, 2023 | -60.74M |
| December 31, 2022 | -96.28M |
| September 30, 2022 | -156.93M |
| June 30, 2022 | -162.38M |
| March 31, 2022 | -274.86M |
| December 31, 2021 | -282.02M |
| September 30, 2021 | -299.16M |
| June 30, 2021 | -299.58M |
| March 31, 2021 | -392.29M |
| December 31, 2020 | -383.46M |
| September 30, 2020 | -390.94M |
| June 30, 2020 | -385.57M |
| Date | Value |
|---|---|
| March 31, 2020 | -267.98M |
| December 31, 2019 | -279.66M |
| September 30, 2019 | -245.23M |
| June 30, 2019 | -216.69M |
| March 31, 2019 | -192.59M |
| December 31, 2018 | -143.59M |
| September 30, 2018 | -68.01M |
| June 30, 2018 | -65.10M |
| March 31, 2018 | -52.55M |
| December 31, 2017 | -73.67M |
| September 30, 2017 | -127.06M |
| June 30, 2017 | -140.23M |
| March 31, 2017 | -154.49M |
| December 31, 2016 | -135.75M |
| September 30, 2016 | -117.74M |
| June 30, 2016 | -100.91M |
| March 31, 2016 | -75.82M |
| December 31, 2015 | -60.72M |
| September 30, 2015 | -51.23M |
| June 30, 2015 | -41.10M |
| March 31, 2015 | -38.03M |
| December 31, 2014 | -123.93M |
| September 30, 2014 | -122.54M |
| June 30, 2014 | -116.96M |
| March 31, 2014 | -112.17M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Emergent BioSolutions, Inc. | -176.80M |
| Exelixis, Inc. | 860.62M |
| ADMA Biologics, Inc. | 168.96M |
| Arcutis Biotherapeutics, Inc. | 28.52M |
| Relay Therapeutics, Inc. | -286.04M |